{"id":"https://openalex.org/W1978342865","doi":"https://doi.org/10.1001/archneur.58.3.417","title":"Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression","display_name":"Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression","alternate_titles":[],"publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W1978342865","doi":"https://doi.org/10.1001/archneur.58.3.417","mag":"1978342865","pmid":"https://pubmed.ncbi.nlm.nih.gov/11255445"},"language":"en","primary_location":{"id":"doi:10.1001/archneur.58.3.417","doi":"https://doi.org/10.1001/archneur.58.3.417","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archneur.58.3.417","pdf_url":null,"source":{"id":"https://openalex.org/S4210230857","display_name":"Archives of Neurology","issn_l":"0003-9942","issn":["0003-9942","1538-3687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978342865"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071364728","display_name":"Martin Rhys Farlow","orcid":"https://orcid.org/0000-0001-7897-5471","observed_orcids":["https://orcid.org/0000-0001-7897-5471"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martin R. Farlow","raw_affiliation_strings":["Department of Neurology, Indiana University School of Medicine, CL583, 541 Clinical Dr., Indianapolis, IN 46202-5111, USA. mfarlow@iupui.edu","Department of Neurology, Indiana University School of Medicine, CL583, 541 Clinical Dr., Indianapolis, IN 46202-5111, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Indiana University School of Medicine, CL583, 541 Clinical Dr., Indianapolis, IN 46202-5111, USA. mfarlow@iupui.edu","institution_ids":["https://openalex.org/I4394709130","https://openalex.org/I55769427"]},{"raw_affiliation_string":"Department of Neurology, Indiana University School of Medicine, CL583, 541 Clinical Dr., Indianapolis, IN 46202-5111, USA","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012811609","display_name":"Ann Marie Hake","orcid":"https://orcid.org/0000-0001-7134-5485","observed_orcids":["https://orcid.org/0000-0001-7134-5485"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ann Hake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077352083","display_name":"John C. Messina","orcid":"https://orcid.org/0000-0003-0167-2151","observed_orcids":["https://orcid.org/0000-0003-0167-2151"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Messina","raw_affiliation_strings":["University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027000513","display_name":"Richard D. Hartman","orcid":"https://orcid.org/0000-0002-3078-3814","observed_orcids":["https://orcid.org/0000-0002-3078-3814"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Hartman","raw_affiliation_strings":["University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108369247","display_name":"Jeffrey Veach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Veach","raw_affiliation_strings":["University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University School of Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103436306","display_name":"Ravi Anand","orcid":"https://orcid.org/0000-0002-7204-7786","observed_orcids":["https://orcid.org/0000-0002-7204-7786"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ravi Anand","raw_affiliation_strings":["University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University School of Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5071364728"],"corresponding_institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130","https://openalex.org/I55769427"],"apc_list":null,"apc_paid":null,"fwci":5.4874,"has_fulltext":false,"cited_by_count":106,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96054681,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"58","issue":"3","first_page":"417","last_page":"422"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8246999979019165,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8246999979019165,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.13330000638961792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.03880000114440918,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/disease-progression-rate","display_name":"disease progression rate","score":0.8460000157356262},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.9739999771118164},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.6060000061988831},{"id":"https://openalex.org/keywords/adas-cog","display_name":"ADAS-Cog","score":0.7390000224113464},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9758619070053101},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7406020164489746},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7074654698371887},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.5192744731903076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5038313269615173},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4813274145126343},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.453653484582901},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41840308904647827},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3058720529079437},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05002105236053467},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/archneur.58.3.417","doi":"https://doi.org/10.1001/archneur.58.3.417","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archneur.58.3.417","pdf_url":null,"source":{"id":"https://openalex.org/S4210230857","display_name":"Archives of Neurology","issn_l":"0003-9942","issn":["0003-9942","1538-3687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Neurology","raw_type":"journal-article"},{"id":"pmid:11255445","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11255445","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G135197880","display_name":"Indiana Alzheimer Disease Center","funder_award_id":"P30AG010133","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G1713611156","display_name":null,"funder_award_id":"P30 AG10133-08","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W961590786","https://openalex.org/W1472735294","https://openalex.org/W1582930821","https://openalex.org/W1644143258","https://openalex.org/W1847168837","https://openalex.org/W1872529562","https://openalex.org/W1953027527","https://openalex.org/W1975272872","https://openalex.org/W1980525435","https://openalex.org/W1981961320","https://openalex.org/W1995006422","https://openalex.org/W2008251385","https://openalex.org/W2012535452","https://openalex.org/W2020961258","https://openalex.org/W2037392579","https://openalex.org/W2061155471","https://openalex.org/W2071984020","https://openalex.org/W2074964051","https://openalex.org/W2085258054","https://openalex.org/W2128136330","https://openalex.org/W2395295802","https://openalex.org/W2466124716","https://openalex.org/W3216169949"],"related_works":["https://openalex.org/W2074232386","https://openalex.org/W15207001","https://openalex.org/W2086240173","https://openalex.org/W1996788686","https://openalex.org/W2137615734","https://openalex.org/W2072249708","https://openalex.org/W2171539930","https://openalex.org/W3213421629","https://openalex.org/W2001715540","https://openalex.org/W2037468903"],"abstract_inverted_index":{"BACKGROUND:":[0],"Evidence":[1],"suggests":[2],"that":[3],"disease":[4,13,24,39,247,283,288,309],"severity":[5],"predicts":[6,27],"the":[7,20,80,97,101,181,220,271],"response":[8,28,45,261,300],"of":[9,22,38,87,100,186,195,200,233,256,287],"patients":[10,52,89,155,173,211,291],"with":[11,53,105,175,270,292,305],"Alzheimer":[12],"(AD)":[14],"to":[15,29,46,55,92,121,230,262,294,298,301,314],"cholinesterase":[16],"inhibitor":[17],"treatment,":[18,119],"raising":[19],"question":[21],"whether":[23,36],"progression":[25,40,248,289],"also":[26,267],"this":[30],"treatment.":[31,170,303],"OBJECTIVE:":[32],"To":[33],"evaluate":[34],"retrospectively":[35],"rate":[37,249],"during":[41,150,166],"placebo":[42,94,169,252],"treatment":[43,95,112,197,234,253],"affects":[44],"subsequent":[47],"rivastigmine":[48,118,188,196,263,302,317],"tartrate":[49],"therapy":[50,153],"for":[51,113,124,241,282,290],"mild":[54,293],"moderately":[56],"severe":[57],"AD.":[58],"DESIGN:":[59],"A":[60],"26-week,":[61,67],"open-label":[62,106,151,187],"extension":[63,108,152],"study":[64],"following":[65],"a":[66,176,213,244,257],"double-blind,":[68],"randomized,":[69],"placebo-controlled":[70],"trial.":[71],"SETTING:":[72],"Outpatient":[73],"research":[74],"centers":[75],"at":[76,192,225],"22":[77],"sites":[78],"in":[79,96,180],"United":[81],"States.":[82],"PATIENTS:":[83],"We":[84],"studied":[85],"187":[86],"235":[88],"originally":[90],"randomized":[91],"receive":[93],"double-blind":[98,168],"phase":[99],"trial":[102],"who":[103,156,162],"continued":[104],"(rivastigmine)":[107],"therapy.":[109,264,318],"INTERVENTION:":[110],"Placebo":[111],"26":[114,125,183,222,232],"weeks":[115,194,227],"followed":[116],"by":[117],"2":[120],"12":[122,193,226],"mg/d,":[123],"weeks.":[126],"MAIN":[127],"OUTCOME":[128],"MEASURES:":[129],"Alzheimer's":[130],"Disease":[131],"Assessment":[132],"Scale-cognitive":[133],"subscale":[134],"(ADAS-Cog),":[135],"Progressive":[136],"Deterioration":[137,144],"Scale,":[138],"Mini-Mental":[139],"State":[140],"Examination,":[141],"and":[142,160,235,276],"Global":[143],"Scale":[145],"scores.":[146],"RESULTS:":[147],"Rivastigmine":[148],"administration":[149],"benefited":[154],"had":[157,163,212],"progressed":[158,164],"slowly":[159,236],"those":[161],"rapidly":[165,209,307],"initial":[167],"Slowly":[171],"progressive":[172,210,237,308],"responded":[174],"mean":[177,216],"1.03-point":[178],"improvement":[179,218],"week":[182,205,221,231],"(ie,":[184],"start":[185],"treatment)":[189],"ADAS-Cog":[190,223],"score":[191,224],"(week":[198],"38":[199],"treatment;":[201],"P":[202],"=.02":[203],"vs":[204],"26).":[206],"However,":[207],"more":[208,245,306],"significantly":[214,258],"larger":[215],"4.97-point":[217],"from":[219,316],"(with":[228],"respect":[229],"patient":[238,260],"scores,":[239],"P<.001":[240],"both).":[242],"Thus,":[243],"rapid":[246],"while":[250],"receiving":[251],"was":[254,268,277],"predictive":[255],"stronger":[259],"This":[265],"relation":[266],"observed":[269],"other":[272],"3":[273],"outcome":[274],"measures":[275],"still":[278],"apparent":[279],"when":[280],"accounting":[281],"severity.":[284],"CONCLUSIONS:":[285],"Rate":[286],"moderate":[295],"AD":[296],"seems":[297],"predict":[299],"Patients":[304],"might":[310],"be":[311],"particularly":[312],"likely":[313],"benefit":[315]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978342865","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
